REL, a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis

We conducted a genome-wide association study of rheumatoid arthritis in 2,418 cases and 4,504 controls from North America and identified an association at the REL locus, encoding c-Rel, on chromosome 2p13 (rs13031237, P = 6.01 × 10−10). Replication in independent case-control datasets comprising 2,604 cases and 2,882 controls confirmed this association, yielding an allelic OR = 1.25 (P = 3.08 × 10−14) for marker rs13031237 and an allelic OR = 1.21 (P = 2.60 × 10−11) for marker rs13017599 in the combined dataset. The combined dataset also provides definitive support for associations at both CTLA4 (rs231735; OR = 0.85; P = 6.25 × 10−9) and BLK (rs2736340; OR = 1.19; P = 5.69 × 10−9). c-Rel is an NF-κB family member with distinct functional properties in hematopoietic cells, and its association with rheumatoid arthritis suggests disease pathways that involve other recently identified rheumatoid arthritis susceptibility genes including CD40, TRAF1, TNFAIP3 and PRKCQ.

[1]  Hyon K. Choi,et al.  Predicting mortality in patients with rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[2]  S. Ghosh,et al.  NF-κB and the immune response , 2006, Oncogene.

[3]  L. Pham,et al.  Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. , 2007, Blood.

[4]  F. Wolfe,et al.  HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. , 2002, Arthritis and rheumatism.

[5]  S. Gabriel,et al.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis , 2007, Nature Genetics.

[6]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[7]  G. Galbraith,et al.  TRAF1-C5 as a Risk Locus for Rheumatoid Arthritis—A Genomewide Study , 2008 .

[8]  Kristina T. Lu,et al.  c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient. , 2006, Blood.

[9]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[10]  Xiayi Ke,et al.  Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13 , 2008, Nature Genetics.

[11]  Meredith O'Keeffe,et al.  C-Rel Regulates Interleukin 12 P70 Expression in Cd8+ Dendritic Cells by Specifically Inducing p35 Gene Transcription , 2001, The Journal of experimental medicine.

[12]  Stephen B. Johnson,et al.  The New York cancer project: Rationale, organization, design, and baseline characteristics , 2004, Journal of Urban Health.

[13]  J. Hazes,et al.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.

[14]  M Bruinenberg,et al.  Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling , 2009, Gut.

[15]  P. Gregersen,et al.  Rheumatoid arthritis: a view of the current genetic landscape , 2009, Genes and Immunity.

[16]  G. Illei,et al.  A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. , 2003, Arthritis and rheumatism.

[17]  E. Pennisi.  17q21.31: Not Your Average Genomic Address , 2008, Science.

[18]  Geoffrey Hom,et al.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.

[19]  P. Scherle,et al.  Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. , 2003, Arthritis and rheumatism.

[20]  Jing Cui,et al.  Common variants at CD40 and other loci confer risk of rheumatoid arthritis , 2008, Nature Genetics.

[21]  P. Gregersen,et al.  Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. , 2009, Arthritis and rheumatism.

[22]  T. Behrens,et al.  c-Rel Is Required for the Protection of B Cells from Antigen Receptor-Mediated, But Not Fas-Mediated, Apoptosis1 , 2001, The Journal of Immunology.

[23]  Jun Wang,et al.  Genome-Wide Analysis of Gene Expression in T Cells to Identify Targets of the NF-κB Transcription Factor c-Rel1 , 2007, The Journal of Immunology.

[24]  Y. Shoenfeld,et al.  The Role of CD40–CD154 Interactions in Autoimmunity and the Benefit of Disrupting this Pathway , 2004, Autoimmunity.

[25]  Annette Lee,et al.  Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .

[26]  T. Pincus,et al.  An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States. , 2005, Clinical and experimental rheumatology.

[27]  Peter K Gregersen,et al.  Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. , 2009, Arthritis and rheumatism.

[28]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[29]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[30]  Y. Obata,et al.  A Proximal κB Site in the IL-23 p19 Promoter Is Responsible for RelA- and c-Rel-Dependent Transcription , 2007, The Journal of Immunology.